| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/21/2005 | US20050158753 Using presence of gastrointestinal system protein (CS141) as diagnostic indcator of gastrointestinal disorders; diagnosing colon and rectum cancer |
| 07/21/2005 | US20050158714 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis |
| 07/21/2005 | US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself |
| 07/21/2005 | US20050158346 Vaccine against Haemophilus influenzae type a, Haemophilus influenzae type b, Staphylococcus aureus, and Staphylococcus epidermidis; glycoconjugate of cell wall polysaccharide from Bacillus pumilus Sh 18 |
| 07/21/2005 | US20050158345 ABC (ATP-binding cassette) transporters; polynucleotides, expression vectors, transformed host cells and antibodies; use in vaccination |
| 07/21/2005 | US20050158343 Non-B, non-C, non-G hepatitis virus gene, polynucleotide, polypeptide, virus particle, method for isolating virus particle, and method for detecting virus |
| 07/21/2005 | US20050158326 Compositions for reducing virus infection rate in aquatic crustaceans and applications thereof |
| 07/21/2005 | US20050158324 Using anti-Beta Casein Like Protein antibodies specific for cancer cells as antiproliferative agents; measuring and comparing BCLP mRNA expression to normal tissue to diagnose colon, breast, lung, ovary, prostate, pancreas or skin cancers; tissue-targeted therapy |
| 07/21/2005 | US20050158323 Via antibodies specific for antigen C35; host cells |
| 07/21/2005 | US20050158322 Single chain Fv antibody fragments; for diagnosis/prognosis of human colorectal tumors |
| 07/21/2005 | US20050158321 Drug screening; for methotrexate resistant patients |
| 07/21/2005 | US20050158319 Pharmaceutical composition containing inhibitors of interferon-gamma |
| 07/21/2005 | US20050158318 Method of preventing or treating pain |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158316 For treating hemorrhagic shock |
| 07/21/2005 | US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore |
| 07/21/2005 | US20050158314 For treating chronic immune system disorders, inhibiting rejection of transplanted tissue |
| 07/21/2005 | US20050158313 Immunoglobulins; competitive binding; gene expression inhibition; for prevention and treatment of gastrointestinal tract cancers, inflammatory bowel disorders, and diabetes |
| 07/21/2005 | US20050158310 Via modulating insulin receptor signaling in adipocyte tissue; transgenic/knockout animal; RNA interference |
| 07/21/2005 | US20050158308 For treating, preventing, or ameliorating bone-related or cartilage-related diseases such as osteoporosis; transgenic, knock-out mammals; immunization |
| 07/21/2005 | US20050158307 Such as rheumatoid arthritis and diabetes; antibodies; kits |
| 07/21/2005 | US20050158306 Treatment for neuro-degenerative disease by a blood cleansing system using monoclonal antibodies |
| 07/21/2005 | US20050158305 Monoclonal antibody for treatment of cancer, autoimmune diseases and rheumatoid arthritis; complementarity determining regions |
| 07/21/2005 | US20050158304 chimeric or humanized antibody that specifically binds to an epitope witin residues 1-3 of A beta and a carrier, especially for sustained release |
| 07/21/2005 | US20050158297 treating deficiency in mannan binding lectin-associated serine protease-2 (MASP-2) by administering intravenously an amino acid sequence that is a serine protease that acts in the mannan binding Lectin complement fixation pathway |
| 07/21/2005 | US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers |
| 07/21/2005 | US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers |
| 07/21/2005 | DE10361629A1 Monoclonal antibody, for the recognition of prion proteins, is derived from a cultivation of a hybridoma cell line for use in veterinary and human diagnosis |
| 07/21/2005 | CA2552590A1 Interleukin-12 targeted to oncofoetal fibronectin |
| 07/21/2005 | CA2552188A1 Polypeptides and immunogenic conjugates capable of inducing antibodies against pathogens, and uses thereof |
| 07/21/2005 | CA2551913A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment |
| 07/21/2005 | CA2550245A1 Fibroblast growth factor receptors 1, 2, 3, and 4 as targets for therapeutic intervention |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/21/2005 | CA2548179A1 Methods and compositions for the production of monoclonal antibodies |
| 07/20/2005 | EP1555328A2 Recombinant library screening methods |
| 07/20/2005 | EP1555322A1 Lipolytic enzyme variant |
| 07/20/2005 | EP1555270A1 HCV NS3 proteins and nucleic acids |
| 07/20/2005 | EP1554579A2 Methods of secretory vimentin detection and modulation |
| 07/20/2005 | EP1554572A2 Compositions and methods for modulating blood-brain barrier transport |
| 07/20/2005 | EP1554392A2 Identification of novel broadly cross-reactive neutralizing human monoclonal antibodies using sequential antigen panning of phage display libraries |
| 07/20/2005 | EP1554313A1 Regulation of the cre recombinase using a dissociation/re-association system of said recombinase |
| 07/20/2005 | EP1554312A2 Neutralizing antibodies against gdf-8 and uses therefor |
| 07/20/2005 | EP1554311A2 Humanized antibodies that recognize beta amyloid peptide |
| 07/20/2005 | EP1554310A1 Epididymis-specific gene as potential contraceptive target |
| 07/20/2005 | EP1554309A2 Antibodies and cyclic peptides which bind cea (carcinoembryonic antigen) and their use as cancer therapeutics |
| 07/20/2005 | EP1553980A2 Nucleic acid and corresponding protein entitled 238p1b2 useful in treatment and detection of cancer |
| 07/20/2005 | EP1553976A2 Hiv envelope-cd4 complexes and hybrids |
| 07/20/2005 | EP1553975A2 Optimized fc variants and methods for their generation |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553832A2 Cell separation compositions and methods |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1176194B1 Method of cell cultivation |
| 07/20/2005 | EP0979281B1 A method for making multispecific antibodies having heteromultimeric and common components |
| 07/20/2005 | EP0977878B1 Dna sequences coding for subunit chld of plant magnesium chelatases for determining their action |
| 07/20/2005 | EP0934407B1 Polycation-sensing receptor in aquatic species and methods of use thereof |
| 07/20/2005 | EP0812191B1 Peptides for the treatment of cancer |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643136A Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 07/20/2005 | CN1643133A Chimeric pancreas |
| 07/20/2005 | CN1642984A Specific Ab1'-antibodies against tumour-associated antigen CA 125 |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642982A Agents that activate or inhibit Toll-like receptor 9 |
| 07/20/2005 | CN1642981A Antibody recognizing proliferative human liver cells proliferative human liver cells and functional human liver cells |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642976A A mutated immunoglobulin-binding protein |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1641353A Analyzing and typing monoclonal proteins by capillary electrophoresis and immunodisplacement |
| 07/20/2005 | CN1641033A Novel marneffei penicillium TIM9 protein and its coding sequence |
| 07/20/2005 | CN1641032A Novel marneffei penicillium ERG25 Gene and its coding protein |
| 07/20/2005 | CN1641031A Novel marneffei penicillium TIM17 protein and its coding sequence |
| 07/20/2005 | CN1211486C A DNA molecule encoding mutant prepro-neuropeptide Y, a mutant signal peptide, and uses thereof |
| 07/20/2005 | CN1211123C Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 07/19/2005 | US6919436 Isolation of proteins |
| 07/19/2005 | US6919435 Comprises cancer marker glycoprotein for diagnosis of stomach, colon and breast cancers |
| 07/19/2005 | US6919432 Substances and their uses |
| 07/19/2005 | US6919428 Detergent compositions comprising benefit agents |
| 07/19/2005 | US6919206 Medium containing flt3 ligand for culturing hematophoietic cells |
| 07/19/2005 | US6919183 Detecting and isolating cells that produce preferential protein; obtain cells, transfrom cells with vector containing preferential protein, detect protein on surface of cell, isolate cells displaying preferential protein |
| 07/19/2005 | US6919077 LFA-1 alpha subunit antibodies and methods of use |
| 07/19/2005 | US6919075 Bacteriophage displaying aβ epitopes and method of use |
| 07/19/2005 | US6919070 Stomatic composition |
| 07/19/2005 | US6919021 Simulated activity of Protein A displayed by ligands attached to a cellulose bead surface |
| 07/19/2005 | CA1341486C Modified protein a |
| 07/14/2005 | WO2005064336A1 Pyrenyloxysulfonic acid fluorescent agents |
| 07/14/2005 | WO2005064332A1 Highly active lysophosphatidic acid and method of screening therewith |
| 07/14/2005 | WO2005064021A2 Vaccine |
| 07/14/2005 | WO2005063992A1 Novel serum type streptococcus mutans and utilization of the same |
| 07/14/2005 | WO2005063987A1 Gp153: methods and compositions for treating cancer |
| 07/14/2005 | WO2005063986A1 Immune response regulatory protein |
| 07/14/2005 | WO2005063981A1 Mutants of anti-cd40 antibody |
| 07/14/2005 | WO2005063978A1 Fraction and antibody comprising guinea pig immunoglobulin e |
| 07/14/2005 | WO2005063964A1 Fkbp type ppiase, expression vector, transformant, fused protein, method of producing fused protein, method of producing target protein, method of purifying kfbp type ppiase and method of purifying fused protein |
| 07/14/2005 | WO2005063820A2 Il-7 fusion proteins |
| 07/14/2005 | WO2005063819A2 Human binding molecule against cd1a |
| 07/14/2005 | WO2005063818A1 A process for preparing egg yolk antibodies |
| 07/14/2005 | WO2005063817A2 Methods for identifying functional antibodies |
| 07/14/2005 | WO2005063816A2 Monovalent antibody fragments useful as therapeutics |
| 07/14/2005 | WO2005063815A2 Fcϝ receptor-binding polypeptide variants and methods related thereto |